Kunihiro Matsushita, Josef Coresh, Yingying Sang, John Chalmers, Caroline Fox, Eliseo Guallar, Tazeen Jafar, Simerjot K Jassal, Gijs W D Landman, Paul Muntner, Paul Roderick, Toshimi Sairenchi, Ben Schöttker, Anoop Shankar, Michael Shlipak, Marcello Tonelli, Jonathan Townend, Arjan van Zuilen, Kazumasa Yamagishi, Kentaro Yamashita, Ron Gansevoort, Mark Sarnak, David G Warnock, Mark Woodward, Johan Ärnlöv, CKD Prognosis Consortium
Estimated glomerular filtration rate and albumin-to-creatinine ratio testing for cardiovascular risk assessment
Johan Sundström, Johan Bodegard, Andreas Bollmann, Marc G Vervloet, Patrick B Mark, Avraham Karasik, Tiago Taveira-Gomes, Manuel Botana, Kåre I Birkeland, Marcus Thuresson, Levy Jäger, Manish M Sood, Gijs VanPottelbergh, Navdeep Tangri; on behalf of the CaReMe CKD Investigators
Prevalence, outcomes and cost of chronic kidney disease
Alessandro Gasparini, Marie Evans, Josef Coresh, Morgan E Grams, Olof Norin, Abdul R Qureshi, Björn Runesson, Peter Barany, Johan Ärnlöv, Tomas Jernberg, Björn Wettermark, Carl G Elinder, Juan-Jesüs Carrero
Albuminuria testing in diabetic patients and chronic kidney disease
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Should you screen for kidney damage? What do the guidelines say?
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease
Gain the latest insights on respiratory infections and related rapid tests aimed at expediting appropriate isolation decisions and antiviral treatments. Be informed on the technology differences in diagnostic test methods and hear use cases on testing protocols focused on efficient patient management and quality initiatives, including antimicrobial stewardship.
Respiratory Season: New Diagnostic Challenges and Strategies for Antimicrobial Stewardship
With telehealth and remote treatment on the rise, a unique and international group of experts from USA and Sweden will analyse how rapid point-of-care testing for HbA1c may benefit patients and support screening for undiagnosed diabetes and prediabetes in slowing the progression of diabetes and improving health equity.
The diagnosis moment: – the role of POCT HbA1c in undiagnosed diabetes and prediabetes in plowing the progression of diabetes and improving health equ...
This webinar will discuss screening for and prevention of chronic disease in severe mental illness (SMI) patients and patients with learning disabilities (LD).
The value of POCT in SMI health checks and patients with learning disabilities for the diagnosis, management and monitoring of diabetes and cardiovasc...
In this new webinar session, Doctor Nguyen explores the impact of the implementation of rapid molecular biology tests in the emergency department and the impact on patients care management within the emergency room.
Clinical and operational impact of rapid point-of-care SARS-COV-2 detection in an emergency department
Albuminuria, commonly measured as urine albumin-to-creatinine ratio (ACR), is an under-recognized component of chronic kidney disease (CKD) definition, staging and prognosis.
Albuminuria, elevated serum creatinine and low estimated glomerular filtration rate (eGFR) are key indicators of kidney decline. However, it is unclear if these biomarkers are independent predictors of kidney disease progression in people with type 2 diabetes mellitus (T2DM).
ACR and eGFR as predictors of cardio-renal outcomes in diabetes and kidney disease
